lupus nephritis
GSK’s Benlysta claims first FDA okay for lupus kidney damage
Phil Taylor
Benlysta, fda, GlaxoSmithKline, lupus, lupus nephritis
0 Comment
X
GSK’s Benlysta claims first FDA okay for lupus kidney damage
https://pharmaphorum.com/news/gsks-benlysta-claims-first-fda-okay-for-lupus-kidney-damage/
AZ fleshes out positive trial of revitalised lupus drug anifrolumab
Phil Taylor
AstraZeneca, autoimmune disease, Gazyvaro, lupus, lupus nephritis, Roche
0 Comment
X
AZ fleshes out positive trial of revitalised lupus drug anifrolumab
https://pharmaphorum.com/news/az-fleshes-out-positive-trial-of-revitalised-lupus-drug-anifrolumab/
Aurinia scores big win in lupus nephritis trial
Andrew McConaghie
Aurinia, lupus nephritis, SLE
0 Comment
Trial is first ever to meet primary endpoint in disease
X
Aurinia scores big win in lupus nephritis trial
https://pharmaphorum.com/news/aurinia-scores-big-win-lupus-nephritis-trial/